Bristol-Myers Squibb is the first big pharma to strike a deal with Volastra Therapeutics, a start-up that has developed a drug discovery platform based on chromosomal instability (CIN), a common but ...

Owkin has enticed another big pharma partner with its artificial intelligence-powered clinical development platform, Bristol-Myers Squibb, which is paying $80 million upfront to tap into its expertise ...

DeepSeek released a preview version of its new V4 model series and made it open source. The model supports an ultra-long context of up to one million tokens and shows improvements in agent ...

As mentioned above, DeepSeek released two versions of the model: V4-pro and V4-flash. The V4-pro model has 1.6 trillion parameters, making it the company’s largest model to date. The smaller V4-flash ...

DeepSeek’s long-awaited flagship V4 model has fallen short of its domestic and US rivals, according to a new analysis, as the Chinese artificial intelligence firm struggles to replicate the ...

China’s AI startup is back a year after it stirred up the AI industry with ‘world-leading’ processing power at a fraction of the cost of other models. The Chinese artificial intelligence company ...

[TheHyperFix] had a problem. He’d spied a brilliant camera slider, but didn’t want to lay out big money to acquire it. The natural solution? Build one! Only, life is seldom so straightforward. The ...

Chinese AI company DeepSeek caused quite a stir last year as it climbed to the top of the App Store charts and beat out incumbents like ChatGPT. That was over a year ago and now the company has ...

On standard, cache-miss pricing, DeepSeek-V4-Pro comes in at roughly one-seventh the cost of GPT-5.5 and about one-sixth (1/6th) the cost of Claude Opus 4.7. With cached input, the gap widens: ...

DeepSeek has slashed prices on its artificial intelligence models, including its latest V4 which now costs 97 per cent less than OpenAI products, potentially triggering a price war in the highly ...

The former leaders of SpringWorks Therapeutics are back with a new biotech venture that is already buzzing from a $300 million series A. Beeline Medicines flew out of stealth today with its stores ...

BEIJING, April 24 (Reuters) - Chinese startup DeepSeek on Friday released a preview version of V4, its new artificial intelligence model adapted to run on Huawei chips, marking another step in China's ...